|
| Press Releases |
|
 |
|
| Thursday, December 24, 2020 |
|
|
AIM ImmunoTech Announces that the ME/CFS Clinical Trial of its Drug Ampligen is Open for Enrollment to COVID-19 'Long Haulers' |
AIM ImmunoTech Inc. (NYSE American: AIM) announced today that the post-COVID-19 "Long Hauler" portion of the active AMP-511 Expanded Access Program (EAP) protocol received approval from the Institutional Review Board (IRB) for a solicitation of patient enrollment. Patients in the trial are treated with AIM's flagship pipeline drug Ampligen.
more info >> |
|
| Thursday, February 27, 2020 |
|
|
AIM ImmunoTech joins with ChinaGoAbroad for Ampligen China Entry against COVID-19 |
| AIM ImmunoTech (NYSE American: AIM, or the Company) today announced that the Company has joined with ChinaGoAbroad (CGA) to facilitate the entry of AIM's experimental drug Ampligen into the People's Republic of China (PRC) for use as a prophylactic/early-onset therapeutic against COVID-19, the new SARS-like coronavirus infection that has reached epidemic proportions. more info >> |
|
| Tuesday, February 18, 2020 |
|
|
AIM ImmunoTech Issues Stockholder Update on the Potential Role of Ampligen for Use Against the Wuhan Coronavirus Epidemic |
| AIM ImmunoTech (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers, today provided its stockholders with an update on its efforts to develop Ampligen as a protective therapeutic and a vaccine in the new coronavirus epidemic. more info >> |
|
| Tuesday, February 11, 2020 |
|
|
AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen(R) for Use Against the SARS-like Wuhan 2019 Novel Coronavirus |
| AIM ImmunoTech Inc. (NYSE American:AIM) today announced the filing of three provisional patent applications related to its drug candidate Ampligen in the company's efforts toward joining the global health community in the fight against the deadly Wuhan coronavirus that has so far infected approximately 40,000 people and killed almost one thousand, primarily in China. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Singapore online brokerage Tiger Brokers sees strong retail investor growth in Q4 2020 with 108% increase in new user sign ups
Jan 20, 2021 09:00 HKT/SGT
|
|
|
DENSO Collaborates with Aeva to Bring New LiDAR to Market
Jan 20, 2021 08:34 HKT/SGT
|
|
|
DigiCol + AnRKey X Announce True NFT Cross-Platform Interoperability 
Jan 19, 2021 23:00 HKT/SGT
|
|
|
The Fourth Session of the 13th National People's Congress of Henan Province Opens, Tian Lun Gas expects to benefit from the Provincial "14th Five-Year Plan"
Jan 19, 2021 15:00 HKT/SGT
|
|
|
Moonstake Enters a Strategic Partnership with RockX to Support the Polkadot (DOT) Ecosystem
Jan 19, 2021 11:00 HKT/SGT
|
|
|
Mitsubishi Corporation: Commercial Operations Commence at Methanol / Dimethyl Ether Plant in Trinidad and Tobago
Jan 19, 2021 09:25 HKT/SGT
|
|
|
Indonesia's Rimba Raya: World First REDD+ Project Validated for its Impact on all 17 SDGs
Jan 19, 2021 05:00 HKT/SGT
|
|
|
New LeadsRx Ecosystem Attribution Product Enables Transparency Between Online Marketplaces and their Trusted Partners within a First-Party Data Framework
Jan 19, 2021 04:00 HKT/SGT
|
|
|
Sword GRC to Enhance Product Roadmap, Grow Team, and Extend Global Reach With Multi-Million Pound Investment
Jan 19, 2021 04:00 HKT/SGT
|
|
|
Rhotex Inc Launches Environmentally-Sound Options to Crypto Mining
Jan 18, 2021 23:00 HKT/SGT
|
|
|
Blockpass and Matic Announce Integration
Jan 18, 2021 23:00 HKT/SGT
|
|
|
AC Milan to Join Sports Crypto Movement with Launch of $ACM Fan Token
Jan 18, 2021 22:00 HKT/SGT
|
|
|
14th Asian Financial Forum opens today
Jan 18, 2021 19:00 HKT/SGT
|
|
|
TOYOTA GAZOO Racing Targets the Top Step on Classic Season Opener
Jan 18, 2021 17:08 HKT/SGT
|
|
|
Second Overall as Toyota Gazoo Racing Fights To the End of Dakar 2021
Jan 18, 2021 16:30 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
